Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

365 ARTÍCULOS , VIENDO DEL 241 AL 255

Current treatment options for people with Alzheimer's disease in Croatia

Mimica N, Presecki P.

Chem Biol Interact. 2010 Sep 6;187(1-3):409-10. doi: 10.1016/j.cbi.2010.03.029. Epub 2010 Mar 20.

Drugs for Alzheimer's disease

Cranwell-Bruce LA.

Medsurg Nurs. 2010 Jan-Feb;19(1):51-3.

Combination treatments in Alzheimer's disease: risks and benefits

Sobow T.

Expert Rev Neurother. 2010 May;10(5):693-702. doi: 10.1586/ern.10.43.

[Cost of illness in Alzheimer's disease]

Kiencke P, Rychlik R, Grimm C, Daniel D.

Med Klin (Munich). 2010 May;105(5):327-33. doi: 10.1007/s00063-010-1060-4. Epub 2010 May 26.

Overview of Chinese research on senile dementia in mainland China

Song Y, Wang J.

Ageing Res Rev. 2010 Nov;9 Suppl 1:S6-12. doi: 10.1016/j.arr.2010.08.007. Epub 2010 Sep 8.

ACS chemical neuroscience molecule spotlight on dimebon

Hopkins CR.

ACS Chem Neurosci. 2010 Sep 15;1(9):587-8. doi: 10.1021/cn1000588.

How does diabetes accelerate Alzheimer disease pathology?

Sims-Robinson C, Kim B, Rosko A, Feldman EL.

Nat Rev Neurol. 2010 Oct;6(10):551-9. doi: 10.1038/nrneurol.2010.130. Epub 2010 Sep 14.

The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease

Rockwood K, Fay S, Gorman M.

Int J Geriatr Psychiatry. 2010 Feb;25(2):191-201. doi: 10.1002/gps.2319.

Assessing the relationship between health utilities, quality of life, and health care costs in Alzheimer's disease: the CATIE-AD study

Miller EA, Rosenheck RA, Schneider LS.

Curr Alzheimer Res. 2010 Jun;7(4):348-57. doi: 10.2174/156720510791162386.

Antidepressant use in Alzheimer's disease patients: results of the REAL.FR cohort

Arbus C, Gardette V, Bui E, Cantet C, Andrieu S, Nourhashémi F, Schmitt L, Vellas B; REAL.FR Group.

Int Psychogeriatr. 2010 Feb;22(1):120-8. doi: 10.1017/S1041610209990780. Epub 2009 Sep 7.

Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease

Penner J, Rupsingh R, Smith M, Wells JL, Borrie MJ, Bartha R.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):104-10. doi: 10.1016/j.pnpbp.2009.10.007. Epub 2009 Oct 13.

Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2

Plastino M, Fava A, Pirritano D, Cotronei P, Sacco N, Sperlì T, Spanò A, Gallo D, Mungari P, Consoli D, Bosco D.

J Neurol Sci. 2010 Jan 15;288(1-2):112-6. doi: 10.1016/j.jns.2009.09.022.

The progression of cognitive deterioration and regional cerebral blood flow patterns in Alzheimer's disease: a longitudinal SPECT study

Hanyu H, Sato T, Hirao K, Kanetaka H, Iwamoto T, Koizumi K.

J Neurol Sci. 2010 Mar 15;290(1-2):96-101. doi: 10.1016/j.jns.2009.10.022. Epub 2009 Nov 20.

Estimation of plasma IC50 of donepezil for cerebral acetylcholinesterase inhibition in patients with Alzheimer disease using positron emission tomography

Ota T, Shinotoh H, Fukushi K, Kikuchi T, Sato K, Tanaka N, Shimada H, Hirano S, Miyoshi M, Arai H, Suhara T, Irie T.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):74-8. doi: 10.1097/WNF.0b013e3181c71be9.

The role of positron emission tomography imaging of beta-amyloid in patients with Alzheimer's disease

Xiong KL, Yang QW, Gong SG, Zhang WG.

Nucl Med Commun. 2010 Jan;31(1):4-11. doi: 10.1097/mnm.0b013e32833019f3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias